Evidence map›Paper›PMID 41131711›Full record

ArticleThe FEBS journal2026

Sensing of cardiolipin exposure on plasma membranes of apoptotic cells by EryA-mCherry protein.

Luka Žeželj, Tadeja Bele, Anastasija Panevska, Gregor Bajc, Jan Kejžar, Miha Bahun, Nataša Poklar Ulrih, Valentina Levak, Matej Skočaj, Larisa Lara Popošek and 3 more

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Luka ŽeželjDepartment of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia.
Tadeja BeleDepartment of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia.
Anastasija PanevskaDepartment of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia.
Gregor BajcDepartment of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia.
Jan KejžarDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljana, Slovenia.
Miha BahunDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljana, Slovenia.ORCID 0009-0008-5926-3602
Nataša Poklar UlrihDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljana, Slovenia.
Valentina LevakNational Institute of Biology, Ljubljana, Slovenia.
Matej SkočajDepartment of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia.
Larisa Lara PopošekDepartment of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia.
Peter VeraničInstitute of Cell Biology, Faculty of Medicine, University of Ljubljana, Slovenia.
Nataša ResnikInstitute of Cell Biology, Faculty of Medicine, University of Ljubljana, Slovenia.ORCID 0000-0002-3387-3487
Kristina SepčićDepartment of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia.ORCID 0000-0002-4023-5379

Funding

The Slovenian Research and Innovation Agency J3-2521The Slovenian Research and Innovation Agency J4-50147The Slovenian Research and Innovation Agency P1-0207The Slovenian Research and Innovation Agency P3-0108The Slovenian Research and Innovation Agency P4-0121
6 · The paper itself

Abstract

Erylysin A (EryA), an aegerolysin protein produced by the edible king oyster mushroom (Pleurotus eryngii), interacts strongly with an invertebrate-specific membrane sphingolipid ceramide phosphoethanolamine. Recently, a fluorescently fused variant of EryA was shown to bind to artificial and bacterial lipid membranes containing cardiolipin (CL). This tetra-acylated glycerophospholipid, present in bacteria and in inner mitochondrial membranes of eukaryotic cells, was shown to be externalized to the plasma membrane surface during the process of apoptosis. In this work, we evaluated the interaction of EryA-mCherry with CL-containing artificial lipid vesicles and with mammalian cells undergoing apoptosis and compared its binding affinity and specificity to that of the well-established apoptosis marker, annexin V-FITC. Our results show that, in contrast to annexin V-FITC, which binds several negatively charged glycerophospholipids, EryA-mCherry specifically recognizes and binds CL in artificial membrane systems. However, this binding of EryA-mCherry to CL-supplemented membranes is less effective (K

Indexed as

ApoptosisCardiolipinsCell MembraneAnimalsAnnexin A5HumansProtein BindingRecombinant Fusion ProteinsAnnexin A5CardiolipinsRecombinant Fusion Proteinsaegerolysinannexin Vapoptosis markercardiolipinPleurotus

Identifiers

PMID41131711
PMCPMC12914760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.